Veterinary Medicines

Canigen CE/L liofilizzato e solvente per sospensione iniettabile per cani

Authorised
  • Canine distemper virus, strain Lederle, Live
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 601903, Inactivated
  • Canine adenovirus 2, strain Manhattan, Live
Download as PDF

Product identification

Medicine name:
Canigen CE/L liofilizzato e solvente per sospensione iniettabile per cani
Active substance:
  • Canine distemper virus, strain Lederle, Live
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
  • Leptospira interrogans, serovar Canicola, strain 601903, Inactivated
  • Canine adenovirus 2, strain Manhattan, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Lederle, Live
    3.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
    4250.00
    antigen unit(s)
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Canicola, strain 601903, Inactivated
    4350.00
    antigen unit(s)
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain Manhattan, Live
    3.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
      • Unspecified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/11/2025
Download